PAA 5.88% 18.0¢ pharmaust limited

Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-157

  1. 1,615 Posts.
    lightbulb Created with Sketch. 572
    This is what I Trully believe…….it’s working, and as this is a tolerability trial, predominently…..efficacy is showing extremely positive on all three bio markers in the bloods, urine and nfl , the other ones!! Nuero cognitive tests etc, being analysis now, should be out in 2-3 weeks……it also seems very compelling, that all freshly diagnosed patients that get MPL (Monepantel tablets) will not get to a state of progressive disease, so early detection, earlier Monepantel Tablets for rest of life, should equall. Quality free survival.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.010(5.88%)
Mkt cap ! $71.26M
Open High Low Value Volume
18.0¢ 18.5¢ 17.5¢ $137.6K 761.7K

Buyers (Bids)

No. Vol. Price($)
5 35668 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 252472 6
View Market Depth
Last trade - 15.11pm 29/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.010 ( 4.35 %)
Open High Low Volume
17.5¢ 18.5¢ 17.5¢ 615808
Last updated 15.48pm 29/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.